In this episode of This Is Purdue, we’re featuring a Boilermaker whose innovations are changing and saving lives across the world.  

Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery.  

Listen in as Professor Low discusses how the drug works, why the team started using this drug on ovarian cancer patients first, and what attracted him to innovation at Purdue University. (Hint: He’s been a Boilermaker since birth!) 

Learn more about your ad choices. Visit megaphone.fm/adchoices